Can a new drug improve muscle relaxation during surgery?

NCT ID NCT07746726

Not yet recruiting Disease control Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests whether an experimental drug called HRS-9190 can safely and effectively relax muscles during general anesthesia for elective surgery. It compares HRS-9190 to a standard muscle relaxant, rocuronium, in about 320 adults. The study measures how well the drug enables breathing tube placement and maintains muscle relaxation throughout the operation, as well as how quickly patients recover afterward.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HRS-9190, an experimental muscle relaxant drug
What this could lead to: If successful, HRS-9190 could offer an alternative muscle relaxant for surgeries, potentially with faster onset or recovery.
What could go wrong: This is a phase III trial, but results may not confirm superiority over rocuronium. As with any anesthetic drug, there are risks of side effects or unexpected reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMUSCULAR BLOCKADE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROMUSCULAR BLOCKADE

Contacts and locations

Locations

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 410000, China
The Third Xiangya Hospital of Central South University

Changsha, Hunan, 410000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.